Document Detail


Treatment challenges in axial spondylarthritis and future directions.
MedLine Citation:
PMID:  23888365     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Major progress has been made in recent years in the management of axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA). Most predictors of response have been defined for TNF-blocker therapy, and new treatment strategies are being discussed about how to best reach remission and how to maintain remission. Other biologics besides TNF-blockers have been tested in AS but have so far failed. The IL-17/IL-23 cytokines currently seem to be the most interesting targets. Short-term TNF-blocker therapy does not inhibit radiographic progression but long-term might do so. NSAIDs have been proven to inhibit such progression, even after 2 years of treatment. The effect of a combined therapy of NSAIDs with TNF-blockers on the inhibition of new bone formation in AS patients is currently unknown.
Authors:
Joachim Sieper
Related Documents :
16298375 - Can the growth factors pthrp, ihh and vegf, together regulate the development of a long...
6184375 - Interacting role of thyroxine and growth hormone in the hepatic synthesis of alpha 2u-g...
3098195 - Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid...
7431025 - The antineoplastic quassinoids of simaba cuspidata spruce and ailanthus grandis prain.
9325075 - Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlat...
8132355 - Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current rheumatology reports     Volume:  15     ISSN:  1534-6307     ISO Abbreviation:  Curr Rheumatol Rep     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-07-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888970     Medline TA:  Curr Rheumatol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  356     Citation Subset:  IM    
Affiliation:
Medical Department I, Rheumatology, Charitè, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany, joachim.sieper@charite.de.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ocular vasculitis.
Next Document:  Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.